UPDATE 1-AbbVie hepatitis C cocktail succeeds in late-stage study

June 24 (Reuters) - AbbVie Inc said on Wednesday that its hepatitis C cocktail Viekira Pak was effective whether or not it was used in combination with the compound ribavirin against the most common form of the disease, according to data from a late-stage study.